The state of Georgia currently has 17 active clinical trials seeking participants for Type 2 Diabetes research studies. These trials are conducted in various cities, including Atlanta, Augusta, Decatur and Savannah.
A Study of REACT in Subjects With Type 2 Diabetes Mellitus and Chronic Kidney Disease
NCT05099770
Recruiting
The purpose of this study is to assess the safety and efficacy (including durability) of up to 2 REACT injections given 3 months (+30 days) apart and delivered percutaneously into biopsied and non-biopsied contralateral kidneys in participants with T2DM and CKD.
Gender:
ALL
Ages:
Between 30 years and 80 years
Trial Updated:
04/09/2025
Locations: American Clinical Trials, Acworth, Georgia
Conditions: Type 2 Diabetes Mellitus, Chronic Kidney Diseases
Register for Updates
Wild Blueberries for Gut, Brain, and Heart Health in Adults with High Blood Pressure
NCT06735599
Recruiting
The purpose of the study is to determine the effectiveness of wild blueberries on cardiovascular health, cognitive function, and gut microbiota composition in non-Hispanic Black and White adults with elevated blood pressure.
Gender:
ALL
Ages:
Between 45 years and 65 years
Trial Updated:
03/18/2025
Locations: Georgia State University, Atlanta, Georgia
Conditions: Hypertension (without Type 2 Diabetes Mellitus), High Blood Pressure, Male, Female, Adult, Cognition, Endothelial Function (reactive Hyperemia), Oxidative Stress, Diet, Overweight, Body Composition Measurement, Gut Microbiome, Arterial Stiffness, Caucasian Whites, Inflammation, Microvascular Function
Register for Updates
Mobile App Logging for Diabetes in Pregnancy
NCT06005987
Recruiting
To determine the effect of using a mobile app versus paper logs on compliance and percentage in range blood sugars in monitoring blood sugar in pregnant women with diabetes.
Gender:
FEMALE
Ages:
Between 18 years and 100 years
Trial Updated:
01/29/2025
Locations: Augusta University, Augusta, Georgia
Conditions: Gestational Diabetes Mellitus in Pregnancy, Type 2 Diabetes
Register for Updates
Automated Insulin Delivery for Inpatients with Dysglycemia
NCT06418880
Recruiting
This randomized controlled trial will test the efficacy and safety of automated insulin delivery (AID) in hospitalized patients with diabetes (type 1 or type 2) requiring insulin therapy who are admitted to general medical/surgical floors. The main objectives of this study are: * To test the efficacy and safety of AID versus multiple daily insulin injections (MDI) + CGM in the inpatient setting * To determine differences in CGM-derived metrics between AID and MDI plus CGM in the hospital and e... Read More
Gender:
ALL
Ages:
18 years and above
Trial Updated:
01/27/2025
Locations: Grady Health System (non-CRN), Atlanta, Georgia
Conditions: Type 1 Diabetes, Type 2 Diabetes
Register for Updates
Glycemic Excursion Minimization (GEM) to Outshine Health Disparities
NCT06236581
Recruiting
The purpose of this study is to see if the GEM intervention is acceptable and helpful to Black adults with type 2 diabetes. The GEM intervention (coaching to reduce carbohydrate intake and increase physical activity after meals, with feedback from a continuous glucose monitor, CGM) might improve blood glucose levels, reduce diabetes distress, and increase empowerment and confidence in managing diabetes.
Gender:
ALL
Ages:
18 years and above
Trial Updated:
07/29/2024
Locations: Georgia Prevention Institute, Augusta, Georgia
Conditions: Type 2 Diabetes
Register for Updates